Endogenous inhibitors of angiogenesis

Malin Sund, Raghu Kalluri

Research output: Chapter in Book/Report/Conference proceedingChapter

7 Scopus citations

Abstract

During angiogenesis new blood vessels are formed from pre-existing blood vessels. Tumor angiogenesis enables a small colony of malignantly transformed cells to grow and develop into an invasive cancer. This process is believed to be regulated by a change in the balance between endogenous pro-angiogenic and anti-angiogenic factors, and thus tumor growth requires a shift towards pro-angiogenesis. There are now extensive genetic data available from animal models that illustrate that the ceiling growth rate of a cancer is strongly influenced by the angiogenic potential of the host. This concept will be discussed in this chapter. We will also introduce the reader to the known matrix-derived and other endogenous inhibitors on angiogenesis, and their mechanism of action.

Original languageEnglish (US)
Title of host publicationTumor Angiogenesis
Subtitle of host publicationBasic Mechanisms and Cancer Therapy
PublisherSpringer Berlin Heidelberg
Pages215-231
Number of pages17
ISBN (Print)9783540331766
DOIs
StatePublished - 2008
Externally publishedYes

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Endogenous inhibitors of angiogenesis'. Together they form a unique fingerprint.

Cite this